Loading...

Aster DM Healthcare

BSE:540975
Snowflake Description

Solid track record with reasonable growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
540975
BSE
₹75B
Market Cap
  1. Home
  2. IN
  3. Healthcare
Company description

Aster DM Healthcare Limited operates as a healthcare company in the Middle East, India, and the Far East. The last earnings update was 2 days ago. More info.


Add to Portfolio Compare Print
540975 Share Price and Events
7 Day Returns
-0.9%
BSE:540975
-5.6%
IN Healthcare
-3.1%
IN Market
1 Year Returns
-
BSE:540975
-14.7%
IN Healthcare
-9.2%
IN Market
540975 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Aster DM Healthcare (540975) -0.9% -7.3% -3.9% - - -
IN Healthcare -5.6% -7.2% -5% -14.7% -12.9% 36.3%
IN Market -3.1% -3.8% -2.9% -9.2% 43.1% 83.1%
1 Year Return vs Industry and Market
  • No trading data on 540975.
  • No trading data on 540975.
Price Volatility
Industry
5yr Volatility vs Market

Value

 Is Aster DM Healthcare undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Aster DM Healthcare to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Aster DM Healthcare.

BSE:540975 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 4 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 13.5%
Perpetual Growth Rate 10-Year IN Government Bond Rate 7.6%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for BSE:540975
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year IN Govt Bond Rate 7.6%
Equity Risk Premium S&P Global 7.5%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.46
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.461 (1 + (1- 55%) (34.39%))
0.532
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 7.55% + (0.8 * 7.45%)
13.51%

Discounted Cash Flow Calculation for BSE:540975 using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Aster DM Healthcare is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.

BSE:540975 DCF 1st Stage: Next 5 year cash flow forecast
2019 2020 2021 2022 2023
Levered FCF (INR, Millions) -1,392.00 3,452.00 4,736.00 5,510.43 6,392.10
Source Analyst x1 Analyst x1 Analyst x1 Est @ 16.35% Est @ 16%, capped from 16.35%
Present Value
Discounted (@ 13.51%)
-1,226.32 2,679.18 3,238.24 3,319.32 3,392.13
Present value of next 5 years cash flows ₹11,402.55
BSE:540975 DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2023 × (1 + g) ÷ (Discount Rate – g)
= ₹6,392.10 × (1 + 7.55%) ÷ (13.51% – 7.55%)
₹115,347.36
Present Value of Terminal Value = Terminal Value ÷ (1 + r)5
= ₹115,347.36 ÷ (1 + 13.51%)5
₹61,212.07
BSE:540975 Total Equity Value
Calculation Result
Total Equity Value = Present value of next 5 years cash flows + Terminal Value
= ₹11,402.55 + ₹61,212.07
₹72,614.62
Equity Value per Share
(INR)
= Total value / Shares Outstanding
= ₹72,614.62 / 501.52
₹147.24
BSE:540975 Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in BSE:540975 represents 1.01696x of NSEI:ASTERDM
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
1.01696x
Value per Share
(Listing Adjusted, INR)
= Value per Share (INR) x Listing Adjustment Factor
= ₹ 144.79 x 1.01696
₹147.24
Value per share (INR) From above. ₹147.24
Current discount Discount to share price of ₹152.90
= -1 x (₹152.90 - ₹147.24) / ₹147.24
-3.8%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Aster DM Healthcare is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Aster DM Healthcare's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Aster DM Healthcare's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BSE:540975 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in INR ₹6.38
NSEI:ASTERDM Share Price ** NSEI (2019-02-15) in INR ₹150.35
India Healthcare Industry PE Ratio Median Figure of 24 Publicly-Listed Healthcare Companies 28.08x
India Market PE Ratio Median Figure of 2,734 Publicly-Listed Companies 15.39x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Aster DM Healthcare.

BSE:540975 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NSEI:ASTERDM Share Price ÷ EPS (both in INR)

= 150.35 ÷ 6.38

23.55x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Aster DM Healthcare is good value based on earnings compared to the IN Healthcare industry average.
  • Aster DM Healthcare is overvalued based on earnings compared to the India market.
Price based on expected Growth
Does Aster DM Healthcare's expected growth come at a high price?
Raw Data
BSE:540975 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 23.55x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts
30.6%per year
Asia Healthcare Industry PEG Ratio Median Figure of 13 Publicly-Listed Healthcare Companies 1.83x
India Market PEG Ratio Median Figure of 608 Publicly-Listed Companies 1.1x

*Line of best fit is calculated by linear regression .

BSE:540975 PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 23.55x ÷ 30.6%

0.77x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Aster DM Healthcare is good value based on expected growth next year.
Price based on value of assets
What value do investors place on Aster DM Healthcare's assets?
Raw Data
BSE:540975 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in INR ₹59.97
NSEI:ASTERDM Share Price * NSEI (2019-02-15) in INR ₹150.35
India Healthcare Industry PB Ratio Median Figure of 32 Publicly-Listed Healthcare Companies 1.9x
India Market PB Ratio Median Figure of 3,588 Publicly-Listed Companies 1.06x
BSE:540975 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NSEI:ASTERDM Share Price ÷ Book Value per Share (both in INR)

= 150.35 ÷ 59.97

2.51x

* Primary Listing of Aster DM Healthcare.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Aster DM Healthcare is overvalued based on assets compared to the IN Healthcare industry average.
X
Value checks
We assess Aster DM Healthcare's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Aster DM Healthcare has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Aster DM Healthcare expected to perform in the next 1 to 3 years based on estimates from 4 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
30.6%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Aster DM Healthcare expected to grow at an attractive rate?
  • Aster DM Healthcare's earnings growth is expected to exceed the low risk savings rate of 7.6%.
Growth vs Market Checks
  • Aster DM Healthcare's earnings growth is expected to exceed the India market average.
  • Aster DM Healthcare's revenue growth is expected to exceed the India market average.
Annual Growth Rates Comparison
Raw Data
BSE:540975 Future Growth Rates Data Sources
Data Point Source Value (per year)
BSE:540975 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts 30.6%
BSE:540975 Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 4 Analysts 12%
India Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 44.2%
India Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 13%
India Market Earnings Growth Rate Market Cap Weighted Average 18.4%
India Market Revenue Growth Rate Market Cap Weighted Average 11.7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BSE:540975 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
All numbers in INR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BSE:540975 Future Estimates Data
Date (Data in INR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-03-31 99,604 10,151 6,027 3
2020-03-31 91,583 8,029 3,734 4
2019-03-31 79,575 6,616 3,058 3
BSE:540975 Past Financials Data
Date (Data in INR Millions) Revenue Cash Flow Net Income *
2018-12-31 75,460 3,139
2018-09-30 72,102 3,687
2018-06-30 69,394 3,582
2018-03-31 67,212 5,374 2,689
2017-03-31 59,313 3,608 1,018
2016-03-31 52,499 2,027 -590

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Aster DM Healthcare's earnings are expected to grow significantly at over 20% yearly.
  • Aster DM Healthcare's revenue is expected to grow by 12% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BSE:540975 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below

All data from Aster DM Healthcare Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BSE:540975 Future Estimates Data
Date (Data in INR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-03-31 11.90 11.90 11.90 1.00
2020-03-31 7.40 8.30 6.50 2.00
2019-03-31 5.10 6.10 4.10 2.00
BSE:540975 Past Financials Data
Date (Data in INR Millions) EPS *
2018-12-31 6.38
2018-09-30 7.60
2018-06-30 7.53
2018-03-31 5.75
2017-03-31 2.20
2016-03-31 -1.35

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Aster DM Healthcare is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Aster DM Healthcare's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the India market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the India market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Aster DM Healthcare has a total score of 4/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Aster DM Healthcare performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Aster DM Healthcare's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Aster DM Healthcare has delivered over 20% year on year earnings growth in the past 5 years.
  • Aster DM Healthcare's 1-year earnings growth exceeds its 5-year average (37.9% vs 24.3%)
  • Aster DM Healthcare's earnings growth has exceeded the IN Healthcare industry average in the past year (37.9% vs -3.5%).
Earnings and Revenue History
Aster DM Healthcare's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Aster DM Healthcare Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BSE:540975 Past Revenue, Cash Flow and Net Income Data
Date (Data in INR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 75,459.71 3,139.26 4,771.91
2018-09-30 72,101.51 3,687.36 4,543.61
2018-06-30 69,393.71 3,582.06 4,390.91
2018-03-31 67,211.61 2,688.76 4,224.71
2017-03-31 59,312.87 1,017.60 4,120.02
2016-03-31 52,498.90 -590.15 2,994.77
2015-03-31 38,758.43 1,326.92 1,798.06
2014-03-31 28,711.45 1,777.83 1,220.98
2013-03-31 19,217.42 917.81 885.93
2012-03-31 11,814.21 523.05 660.15

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Aster DM Healthcare has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Aster DM Healthcare used its assets more efficiently than the IN Healthcare industry average last year based on Return on Assets.
  • Aster DM Healthcare has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Aster DM Healthcare's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Aster DM Healthcare has a total score of 5/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Aster DM Healthcare's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Aster DM Healthcare's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Aster DM Healthcare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Aster DM Healthcare's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Aster DM Healthcare's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Aster DM Healthcare Company Filings, last reported 1 month ago.

BSE:540975 Past Debt and Equity Data
Date (Data in INR Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 34,026.50 25,934.70 3,438.10
2018-09-30 34,026.50 25,934.70 3,438.10
2018-06-30 31,900.32 23,641.01 2,877.41
2018-03-31 31,900.32 23,641.01 2,877.41
2017-03-31 22,506.77 27,592.72 1,663.82
2016-03-31 5,966.65 33,252.59 3,014.62
2015-03-31 22,461.33 10,927.61 2,854.33
2014-03-31 13,705.81 8,858.55 3,247.36
2013-03-31 11,423.73 5,046.46 2,008.72
2012-03-31 8,870.75 3,322.41 2,299.87
  • Aster DM Healthcare's level of debt (76.2%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (60.3% vs 76.2% today).
  • Debt is well covered by operating cash flow (20.7%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 3.3x coverage).
X
Financial health checks
We assess Aster DM Healthcare's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Aster DM Healthcare has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Aster DM Healthcare's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Aster DM Healthcare dividends. Estimated to be 0% next year.
If you bought ₹2,000 of Aster DM Healthcare shares you are expected to receive ₹0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Aster DM Healthcare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Aster DM Healthcare's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BSE:540975 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
India Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 9 Stocks 0.7%
India Market Average Dividend Yield Market Cap Weighted Average of 1397 Stocks 1.4%
India Minimum Threshold Dividend Yield 10th Percentile 0.3%
India Bottom 25% Dividend Yield 25th Percentile 0.6%
India Top 25% Dividend Yield 75th Percentile 2.1%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BSE:540975 Future Dividends Estimate Data
Date (Data in ₹) Dividend per Share (annual) Avg. No. Analysts
2021-03-31 0.00 1.00
2020-03-31 0.00 1.00
2019-03-31 0.00 1.00

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Aster DM Healthcare has not reported any payouts.
  • Unable to verify if Aster DM Healthcare's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Aster DM Healthcare's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Aster DM Healthcare has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Aster DM Healthcare's dividends in 3 years as they are not expected to pay a notable one for India.
X
Income/ dividend checks
We assess Aster DM Healthcare's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Aster DM Healthcare afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Aster DM Healthcare has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Aster DM Healthcare's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Mandayapurath Moopen
COMPENSATION ₹0
AGE 65
TENURE AS CEO 4.2 years
CEO Bio

Dr. Mandayapurath Azad Moopen, M.D. is the Chairman of Aster DM Healthcare Ltd and has been its Managing Director since December 1, 2014. He is Founder of Aster DM Healthcare Limited. He is a gold medalist in Medicine and a post graduate in General Medicine from University of Calicut, Kerala, India and a diploma holder in Tuberculosis and Chest Diseases from Delhi University, Delhi, India. He is responsible for Company’s overall business operations and is responsible for setting forth the group strategy and vision. He also serves as a director of NORKA Roots. He has set up Dr. Moopen’s Foundation, a charitable foundation for extending healthcare charitable benefits to the less privileged. He has been a Director of Company since its incorporation. He has been honoured by the Government of India with the Padma Shri Award in 2011 and the Pravasi Bharatiya Samman in 2010. He has also been conferred the Best Doctor Award by the Government of Kerala in 2009. He has also received the Arab Health Award from the Arab Health Forum in 2010, the Arabian Business Achievement Award from the ITP Publishing Group in 2010 and the Healthcare CEO of the Year Award at the CEO Middle East Awards 2015. His Directorship in Indian companies includes DM Med City Hospitals (India) Private Limited, Dr. Ramesh Cardiac and Multispeciality Hospital Private Limited, Malabar Institute of Medical Sciences Limited, Norka Roots, Wayanad Infrastructure Private Limited. His Directorship in Foreign Companies Includes AAQ Healthcare Investment LLC, Affinity Holdings Private Limited, Al Rafa Holdings Limited, Al Rafa Investments Limited, Al Rafa Medical Centre LLC, Al Raffah Hospital LLC (Muscat), Al Raffah Medical Centre LLC, Al Raffah Pharmacies Group LLC, Al Shafar Pharmacy LLC, Alfa Drug Store LLC, Aries Holdings FZC, Aster Al Shafar Pharmacies Group LLC, Aster DM Healthcare (SPC), Aster DM Healthcare FZC, Aster DM Healthcare INC, Aster Day Surgery Centre LLC, Aster Medical Centre LLC, Aster Opticals LLC, Aster Pharmacies Group LLC, Aster Pharmacy LLC, Credence High School LLC, Dar Al Shifa Medical Centre LLC, DM Healthcare LLC, DM Pharmacies LLC, Dr. Moopens Healthcare Management Services LLC, Dr. Moopens Healthcare Management Services WLL, Dr. Moopens Medical Clinic LLC, Eurohealth Systems FZ LLC, Ibn Al Haitham Pharmacy LLC, Med Shop Drugs Store LLC, Medcare Hospital LLC, Medshop Garden Pharmacy LLC, Modern Dar Al Shifa Pharmacy LLC, New Aster Pharmacy DMCC, Rafa Pharmacy LLC, Shindhagha Pharmacy LLC, Union Investments Private Limited, Union Pharmacy LLC, Zabeel Pharmacy LLC (under winding up). He also holds Partnership in Learning Chain Education Management LLP and Endeavu Infra Developers LLP. He holds Trusteeship in Aster DM Foundation, DM Education and Research Foundation, Dr. Moopen’s Family Foundation, MIMS Research Foundation, N & M Foundation, DM Healthcare Foundation INC.

CEO Compensation
  • Insufficient data for Mandayapurath to compare compensation growth.
  • Mandayapurath's remuneration is lower than average for companies of similar size in India.
Management Team Tenure

Average tenure and age of the Aster DM Healthcare management team in years:

2.9
Average Tenure
47
Average Age
  • The tenure for the Aster DM Healthcare management team is about average.
Management Team

Mandayapurath Moopen

TITLE
Founder
AGE
65
TENURE
4.2 yrs

Sreenath Reddy

TITLE
Chief Financial Officer
AGE
44
TENURE
6.3 yrs

Harish Pillai

TITLE
CEO of India
AGE
50
TENURE
5.8 yrs

Nitish Shetty

TITLE
Chief Executive Officer of Aster CMI Hospital
AGE
47
TENURE
4.3 yrs

Vinod Ramanunni

TITLE
Chief Business Development Officer
AGE
52

Chandil Gunashekara

TITLE
Chief Executive Officer of Aster Aadhar

Veneeth Purushotaman

TITLE
Group Chief Information Officer
TENURE
1.1 yrs

Puja Aggarwal

TITLE
Company Secretary & Compliance Officer
TENURE
0.5 yrs

Dalia Aziz

TITLE
Chief Marketing & Communications Officer
AGE
47
TENURE
1.7 yrs

Farhat Siddiqi

TITLE
Group Chief Human Resources Officer
AGE
42
TENURE
1.7 yrs
Board of Directors Tenure

Average tenure and age of the Aster DM Healthcare board of directors in years:

3.8
Average Tenure
57
Average Age
  • The tenure for the Aster DM Healthcare board of directors is about average.
Board of Directors

T. Wilson

TITLE
Non-Executive Director
AGE
57
TENURE
9.8 yrs

Maniedath Nambiar

TITLE
Non-Executive Independent Director
COMPENSATION
₹800K
AGE
68
TENURE
3.8 yrs

Mandayapurath Moopen

TITLE
Founder
AGE
65

Alisha Moopen

TITLE
Non-Executive Director
AGE
36
TENURE
5.4 yrs

Anoop Moopen

TITLE
Non-Executive Director
AGE
41
TENURE
9.8 yrs

Shamsudheen Bin Mohideen Mammu Haji

TITLE
Non-Executive Director
AGE
55
TENURE
3.4 yrs

Ravi Prasad

TITLE
Non-Executive Independent Director
COMPENSATION
₹800K
AGE
57
TENURE
3.8 yrs

Dan Snyder

TITLE
Non-Executive Independent Director
COMPENSATION
₹500K
AGE
63
TENURE
3.8 yrs

Suresh Kumar

TITLE
Non-Executive Independent Director
COMPENSATION
₹800K
AGE
67
TENURE
3.4 yrs

Daniel Mintz

TITLE
Non-Executive Director
AGE
56
TENURE
2.3 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Aster DM Healthcare insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (₹) Value (₹)
28. Jan 19 Buy Mandayapurath Moopen Individual 24. Jan 19 25. Jan 19 59,746 ₹161.55 ₹9,651,978
24. Jan 19 Buy Mandayapurath Moopen Individual 23. Jan 19 23. Jan 19 30,000 ₹163.47 ₹4,904,100
22. Jan 19 Buy Mandayapurath Moopen Individual 21. Jan 19 21. Jan 19 13,254 ₹164.29 ₹2,177,500
21. Jan 19 Buy Mandayapurath Moopen Individual 17. Jan 19 18. Jan 19 60,000 ₹165.10 ₹9,905,997
17. Jan 19 Buy Mandayapurath Moopen Individual 16. Jan 19 16. Jan 19 12,000 ₹165.42 ₹1,985,040
16. Jan 19 Buy Mandayapurath Moopen Individual 15. Jan 19 15. Jan 19 16,490 ₹165.30 ₹2,725,775
14. Jan 19 Buy Mandayapurath Moopen Individual 10. Jan 19 11. Jan 19 65,510 ₹162.51 ₹10,646,059
10. Jan 19 Buy Mandayapurath Moopen Individual 09. Jan 19 09. Jan 19 19,102 ₹164.45 ₹3,141,323
08. Jan 19 Buy Mandayapurath Moopen Individual 07. Jan 19 07. Jan 19 18,898 ₹164.64 ₹3,111,366
05. Jan 19 Buy Mandayapurath Moopen Individual 04. Jan 19 04. Jan 19 14,996 ₹160.45 ₹2,406,107
04. Jan 19 Buy Mandayapurath Moopen Individual 03. Jan 19 03. Jan 19 14,207 ₹160.26 ₹2,276,813
02. Jan 19 Buy Mandayapurath Moopen Individual 31. Dec 18 01. Jan 19 69,000 ₹156.64 ₹10,808,370
03. Jan 19 Buy Mandayapurath Moopen Individual 02. Jan 19 02. Jan 19 40,000 ₹159.05 ₹6,362,000
31. Dec 18 Buy Mandayapurath Moopen Individual 27. Dec 18 27. Dec 18 60,000 ₹150.71 ₹9,042,599
27. Dec 18 Buy Mandayapurath Moopen Individual 26. Dec 18 26. Dec 18 60,000 ₹149.94 ₹8,996,399
26. Dec 18 Buy Mandayapurath Moopen Individual 24. Dec 18 24. Dec 18 60,000 ₹152.02 ₹9,121,197
24. Dec 18 Buy Mandayapurath Moopen Individual 20. Dec 18 20. Dec 18 60,000 ₹153.25 ₹9,194,996
21. Dec 18 Buy Mandayapurath Moopen Individual 19. Dec 18 19. Dec 18 39,297 ₹154.58 ₹6,074,528
19. Dec 18 Buy Mandayapurath Moopen Individual 18. Dec 18 18. Dec 18 60,000 ₹152.22 ₹9,133,200
18. Dec 18 Buy Mandayapurath Moopen Individual 17. Dec 18 17. Dec 18 60,000 ₹151.24 ₹9,074,400
17. Dec 18 Buy Mandayapurath Moopen Individual 13. Dec 18 14. Dec 18 78,500 ₹152.19 ₹11,947,270
13. Dec 18 Buy Mandayapurath Moopen Individual 12. Dec 18 12. Dec 18 39,000 ₹151.78 ₹5,919,419
12. Dec 18 Buy Mandayapurath Moopen Individual 11. Dec 18 11. Dec 18 39,341 ₹150.54 ₹5,922,392
11. Dec 18 Buy Mandayapurath Moopen Individual 10. Dec 18 10. Dec 18 40,000 ₹148.34 ₹5,933,599
10. Dec 18 Buy Mandayapurath Moopen Individual 30. Nov 18 07. Dec 18 146,613 ₹149.38 ₹21,901,467
01. Dec 18 Buy Mandayapurath Moopen Individual 29. Nov 18 30. Nov 18 49,046 ₹148.00 ₹7,134,993
07. Dec 18 Buy Ahamed Moopan Individual 26. Nov 18 26. Nov 18 13,500 ₹146.96 ₹1,983,947
05. Oct 18 Buy Athif Moopen Individual 24. Sep 18 26. Sep 18 7,846 ₹156.77 ₹1,230,000
29. Sep 18 Buy Anoop Moopen Individual 27. Sep 18 27. Sep 18 9,216 ₹159.52 ₹1,469,055
27. Sep 18 Buy Anoop Moopen Individual 26. Sep 18 26. Sep 18 8,688 ₹159.02 ₹1,381,585
27. Sep 18 Buy Anoop Moopen Individual 26. Sep 18 26. Sep 18 8,688 ₹159.02 ₹1,381,586
26. Sep 18 Buy Anoop Moopen Individual 25. Sep 18 25. Sep 18 11,150 ₹154.43 ₹1,721,461
25. Sep 18 Buy Anoop Moopen Individual 24. Sep 18 24. Sep 18 9,200 ₹159.71 ₹1,469,349
22. Sep 18 Buy Anoop Moopen Individual 21. Sep 18 21. Sep 18 15,258 ₹160.75 ₹2,452,785
22. Sep 18 Buy Anoop Moopen Individual 21. Sep 18 21. Sep 18 15,258 ₹160.75 ₹2,452,786
19. Sep 18 Buy Anoop Moopen Individual 18. Sep 18 18. Sep 18 17,300 ₹162.00 ₹2,797,847
20. Sep 18 Buy Anoop Moopen Individual 19. Sep 18 19. Sep 18 15,888 ₹161.26 ₹2,559,141
19. Sep 18 Buy Anoop Moopen Individual 18. Sep 18 18. Sep 18 17,300 ₹162.00 ₹2,797,848
18. Sep 18 Buy Anoop Moopen Individual 17. Sep 18 17. Sep 18 13,100 ₹162.11 ₹2,121,990
17. Sep 18 Buy Anoop Moopen Individual 14. Sep 18 14. Sep 18 21,257 ₹163.72 ₹3,433,102
14. Sep 18 Buy Anoop Moopen Individual 12. Sep 18 12. Sep 18 4,243 ₹165.88 ₹702,672
09. Jul 18 Buy Anoop Moopen Individual 02. Jul 18 03. Jul 18 7,960 ₹167.12 ₹1,325,745
07. Jul 18 Buy Anoop Moopen Individual 02. Jul 18 03. Jul 18 7,960 ₹167.12 ₹1,325,747
30. Jun 18 Buy Anoop Moopen Individual 28. Jun 18 29. Jun 18 24,464 ₹173.43 ₹3,919,984
22. Jun 18 Buy Anoop Moopen Individual 20. Jun 18 21. Jun 18 22,973 ₹175.24 ₹4,014,393
22. Jun 18 Buy Anoop Moopen Individual 20. Jun 18 21. Jun 18 22,973 ₹175.24 ₹4,014,397
20. Jun 18 Buy Mandayapurath Moopen Individual 11. Jun 18 13. Jun 18 46,001 ₹187.04 ₹8,569,077
20. Jun 18 Buy Anoop Moopen Individual 12. Jun 18 18. Jun 18 28,780 ₹189.34 ₹5,389,301
12. Jun 18 Buy Anoop Moopen Individual 11. Jun 18 11. Jun 18 3,250 ₹180.19 ₹585,479
11. Jun 18 Buy Mandayapurath Moopen Individual 06. Jun 18 08. Jun 18 63,599 ₹180.63 ₹11,458,670
11. Jun 18 Buy Anoop Moopen Individual 06. Jun 18 08. Jun 18 95,012 ₹180.63 ₹14,679,306
07. Jun 18 Buy Anoop Moopen Individual 05. Jun 18 06. Jun 18 57,594 ₹179.44 ₹10,153,450
04. Jun 18 Buy Anoop Moopen Individual 01. Jun 18 04. Jun 18 41,464 ₹178.45 ₹7,383,128
31. May 18 Buy Anoop Moopen Individual 28. May 18 29. May 18 20,000 ₹180.76 ₹3,607,070
05. May 18 Buy Anoop Moopen Individual 03. May 18 04. May 18 24,700 ₹173.05 ₹4,236,002
04. May 18 Buy Anoop Moopen Individual 02. May 18 02. May 18 6,639 ₹167.44 ₹1,110,991
02. May 18 Buy Alisha Moopen Individual 30. Apr 18 30. Apr 18 30,000 ₹171.07 ₹5,132,098
30. Apr 18 Buy Anoop Moopen Individual 24. Apr 18 27. Apr 18 18,627 ₹168.58 ₹3,109,765
30. Apr 18 Buy Alisha Moopen Individual 27. Apr 18 27. Apr 18 29,000 ₹170.51 ₹4,944,788
27. Apr 18 Buy Alisha Moopen Individual 25. Apr 18 25. Apr 18 29,000 ₹170.21 ₹4,936,088
26. Apr 18 Buy Alisha Moopen Individual 24. Apr 18 24. Apr 18 29,000 ₹169.54 ₹4,916,660
23. Apr 18 Buy Anoop Moopen Individual 18. Apr 18 20. Apr 18 12,593 ₹166.67 ₹2,094,606
16. Apr 18 Buy Anoop Moopen Individual 12. Apr 18 13. Apr 18 13,966 ₹170.00 ₹2,370,473
25. Apr 18 Buy Anoop Moopen Individual 23. Apr 18 23. Apr 18 9,115 ₹166.41 ₹1,514,599
23. Apr 18 Buy Anoop Moopen Individual 18. Apr 18 20. Apr 18 14,362 ₹166.67 ₹2,387,351
18. Apr 18 Buy Anoop Moopen Individual 16. Apr 18 16. Apr 18 1,350 ₹166.00 ₹224,100
12. Apr 18 Buy Anoop Moopen Individual 11. Apr 18 11. Apr 18 6,316 ₹171.75 ₹1,084,421
09. Apr 18 Buy Anoop Moopen Individual 03. Apr 18 04. Apr 18 4,399 ₹169.15 ₹742,885
03. Apr 18 Buy Mandayapurath Moopen Individual 23. Mar 18 28. Mar 18 173,200 ₹172.38 ₹29,820,353
03. Apr 18 Buy Naseera Azad Individual 28. Mar 18 28. Mar 18 144,000 ₹171.08 ₹24,636,077
02. Apr 18 Buy Anoop Moopen Individual 16. Mar 18 28. Mar 18 38,187 ₹167.50 ₹6,040,263
29. Mar 18 Buy Anoop Moopen Individual 26. Mar 18 26. Mar 18 26,600 ₹169.26 ₹4,489,382
16. Mar 18 Buy Anoop Moopen Individual 09. Mar 18 15. Mar 18 436,238 ₹155.32 ₹25,686,999
23. Mar 18 Buy Anoop Moopen Individual 20. Mar 18 21. Mar 18 73,291 ₹173.92 ₹12,498,613
16. Mar 18 Buy Mandayapurath Moopen Individual 14. Mar 18 14. Mar 18 525,720 ₹145.82 ₹76,660,602
26. Mar 18 Buy Anoop Moopen Individual 22. Mar 18 23. Mar 18 34,420 ₹169.54 ₹5,760,837
21. Mar 18 Buy Anoop Moopen Individual 19. Mar 18 19. Mar 18 49,500 ₹160.81 ₹7,959,092
X
Management checks
We assess Aster DM Healthcare's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Aster DM Healthcare has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Map
Description

Aster DM Healthcare Limited operates as a healthcare company in the Middle East, India, and the Far East. It operates hospitals, clinics, pharmacies, diagnostic centers, and retail pharmacies. The company was founded in 1987 and is headquartered in Dubai, the United Arab Emirates.

Details
Name: Aster DM Healthcare Limited
540975
Exchange: BSE
Founded: 1987
₹75,403,950,424
501,522,783
Website: http://asterdmhealthcare.com
Address: Aster DM Healthcare Limited
Tower D - Aspect Tower,
33rd Floor,
Dubai,
United Arab Emirates
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NSEI ASTERDM Equity Shares National Stock Exchange of India IN INR 22. Feb 2018
BSE 540975 Equity Shares Mumbai Stock Exchange IN INR 22. Feb 2018
Number of employees
Current staff
Staff numbers
17,335
Aster DM Healthcare employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/02/15 13:15
End of day share price update: 2019/02/15 00:00
Last estimates confirmation: 2019/02/15
Last earnings filing: 2019/02/13
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.